Kraig Biocraft Laboratories (KBLB) Cash from Financing Activities (2016 - 2022)
Kraig Biocraft Laboratories (KBLB) has disclosed Cash from Financing Activities for 11 consecutive years, with -$15000.0 as the latest value for Q4 2022.
- Quarterly Cash from Financing Activities fell 120.33% to -$15000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2022, down 12.52% year-over-year, with the annual reading at $2.5 million for FY2025, 7102.33% up from the prior year.
- Cash from Financing Activities hit -$15000.0 in Q4 2022 for Kraig Biocraft Laboratories, roughly flat from -$15000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $3.3 million in Q2 2021 to a low of -$15000.0 in Q3 2022.
- Historically, Cash from Financing Activities has averaged $665168.9 across 4 years, with a median of $73774.0 in 2021.
- Biggest five-year swings in Cash from Financing Activities: soared 873.04% in 2019 and later tumbled 120.33% in 2022.
- Year by year, Cash from Financing Activities stood at $57000.0 in 2018, then soared by 1863.16% to $1.1 million in 2019, then tumbled by 93.41% to $73774.0 in 2021, then crashed by 120.33% to -$15000.0 in 2022.
- Business Quant data shows Cash from Financing Activities for KBLB at -$15000.0 in Q4 2022, -$15000.0 in Q3 2022, and $1.4 million in Q2 2022.